The nature of bipolar disorder.
paper
Cited
Public
Unavailable
- Authors
- Manji, H K; Lenox, R H
- Year
- 2000
- Journal
- The Journal of clinical psychiatry
- PMID
- 11153812
The underlying pathophysiology of bipolar disorder is a continually evolving complexity of multilayer interacting and independent systems. The dearth of adequate preclinical or clinical models that incorporate the various features of the illness, i.e., acute and chronic, recurrent and episodic, and time-course and treatment-related variables, has made the consistency and interpretation of data difficult. Newer technologies and the availability of structurally and mechanistically distinct pharmacologic agents have expanded opportunities for experimental study. In addition to the well-known neurotransmitter systems that are disrupted in mood disorders, critical guanine nucleotide-binding protein (G protein)-coupled signaling pathways are implicated in modulating mood state. Regulation of gene expression and identification of factors regulating neuroplasticity and neurotrophic events in the central nervous system in bipolar disorder are 2 of the more recent approaches contributing to clarification of the pathophysiology and potential treatment options.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | 2019 | 30087005 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases. | Silnitsky S et al. | β | 2023 | β |
| Effectiveness of a Smartphone App With a Wearable Activity Tracker in Preventing the Recurrence of Mood Disorders: Prospective Case-Control Study. | Cho CH et al. | β | 2020 | β |
| The Implication of Androgens in the Presence of Protein Kinase C to Repair Alzheimerβs Disease-Induced Cognitive Dysfunction | Amiri S et al. | β | 2020 | β |
| Bipolar spectrum disorders and associated factors among adults attending an antiretroviral therapy clinic in Gedeo zone health centers, southern Ethiopia. | Belayneh Z et al. | β | 2019 | β |
| Lithium-induced gene expression alterations in two peripheral cell models of bipolar disorder. | Kittel-Schneider S et al. | β | 2019 | β |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | β | 2019 | β |
| Lithium ameliorates sleep deprivation-induced mania-like behavior, hypothalamic-pituitary-adrenal (HPA) axis alterations, oxidative stress and elevations of cytokine concentrations in the brain and serum of mice. | Valvassori SS et al. | β | 2017 | β |
| Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application. | Watkins CC et al. | β | 2014 | β |
| Interactions of protein kinase C-Ξ± C1A and C1B domains with membranes: a combined computational and experimental study. | Li J et al. | β | 2014 | β |
| A comparative genomic study in schizophrenic and in bipolar disorder patients, based on microarray expression profiling meta-analysis. | Logotheti M et al. | β | 2013 | β |
| Aripiprazole alone or in combination for acute mania. | Brown R et al. | β | 2013 | β |
| Potential mechanisms of action of lithium in bipolar disorder. Current understanding. | Malhi GS et al. | β | 2013 | β |
| Protein kinase C, an elusive therapeutic target? | Mochly-Rosen D et al. | β | 2012 | β |
| Systems biology, bioinformatics, and biomarkers in neuropsychiatry. | Alawieh A et al. | β | 2012 | β |
| The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder. | Kim HK et al. | β | 2012 | β |
| Disruption of glycogen synthase kinase-3-beta activity leads to abnormalities in physiological measures in mice. | Ahnaou A et al. | β | 2011 | β |
| Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Bipolar Disorder Normalizes after Zinc and Anti-oxidant Therapy. | Russo AJ | β | 2010 | β |
| Ξ²-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network. | Pedrosa E et al. | β | 2010 | β |
| Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients. | Rao JS et al. | β | 2009 | β |
| The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. | Machado-Vieira R et al. | β | 2009 | β |
| Kinases as drug targets in the treatment of bipolar disorder. | Catapano LA et al. | β | 2008 | β |
| Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder. | Huang SY et al. | β | 2008 | β |
| The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. | Du J et al. | β | 2008 | β |
| Chronic treatment with mood stabilizers increases membrane GRK3 in rat frontal cortex. | Ertley RN et al. | β | 2007 | β |
| Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. | Kaladchibachi SA et al. | β | 2007 | β |
| Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia. | Del Zompo M et al. | β | 2007 | β |
| [Treatment-resistant mood disorders]. | Machado-Vieira R et al. | β | 2007 | β |
| Unique association of approach motivation and mania vulnerability. | Meyer B et al. | β | 2007 | β |
| Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. | Sun X et al. | β | 2006 | β |
| Influence of retinoic acid and lithium on proliferation and dopaminergic potential of human NT2 cells. | Misiuta IE et al. | β | 2006 | β |
| Major affective disorders and schizophrenia: a common molecular signature? | Van Den Bogaert A et al. | β | 2006 | β |
| Psychopharmacology of topiramate: from epilepsy to bipolar disorder. | Mula M et al. | β | 2006 | β |
| The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents. | Montezinho LP et al. | β | 2006 | β |
| The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder. | Mundo E et al. | β | 2006 | β |
| A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. | Severino G et al. | β | 2005 | β |
| The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. | Zhou R et al. | β | 2005 | β |
| Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses. | Du J et al. | β | 2004 | β |
| Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. | Du J et al. | β | 2004 | β |
| Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking. | Du J et al. | β | 2004 | β |
| Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder. | Chang A et al. | β | 2003 | β |
| The underlying neurobiology of bipolar disorder. | Manji HK et al. | β | 2003 | β |
| Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. | Koh PO et al. | β | 2003 | β |
| Bipolar I disorder: psychopathology, medical management and dental implications. | Friedlander AH et al. | β | 2002 | β |
| Functional genomics and depression research. Beyond the monoamine hypothesis. | Yamada M et al. | β | 2002 | β |
| Review of the use of topiramate for treatment of bipolar disorders. | Suppes T | β | 2002 | β |